C

Chiome Bioscience Inc
TSE:4583

Watchlist Manager
Chiome Bioscience Inc
TSE:4583
Watchlist
Price: 113 JPY -0.88% Market Closed
Market Cap: ¥7.7B

Operating Margin

-125.7%
Current
Improving
by 37.2%
vs 3-y average of -162.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-125.7%
=
Operating Income
¥-915.3m
/
Revenue
¥728m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-125.7%
=
Operating Income
¥-915.3m
/
Revenue
¥728m

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Chiome Bioscience Inc
TSE:4583
7.7B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.1B USD
Loading...
US
Danaher Corp
NYSE:DHR
167.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83.6T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.8B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
277.8B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 99% of companies in Japan
Percentile
1st
Based on 6 730 companies
1st percentile
-125.7%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Chiome Bioscience Inc
Glance View

Chiome Bioscience, Inc. engages in the development and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) system. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 37 full-time employees. The company went IPO on 2011-12-20. The firm operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.

Intrinsic Value
90.5 JPY
Overvaluation 20%
Intrinsic Value
Price
C
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-125.7%
=
Operating Income
¥-915.3m
/
Revenue
¥728m
What is Chiome Bioscience Inc's current Operating Margin?

The current Operating Margin for Chiome Bioscience Inc is -125.7%, which is above its 3-year median of -162.9%.

How has Operating Margin changed over time?

Over the last 3 years, Chiome Bioscience Inc’s Operating Margin has increased from -251.7% to -125.7%. During this period, it reached a low of -251.7% on Aug 30, 2022 and a high of -123.2% on Mar 31, 2025.

Back to Top